ReviewIndian pediatrics2026
Cough Syrup Tragedies and the Commercial Determinants of Health.
Review in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Honey vs. pharmacological treatment for acute cough in children: a systematic review and meta-analysis of randomized controlled trials.European journal of pediatrics · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Child deaths related to consumption of adulterated cough syrups in India and other low- and middle-income countries highlight an ongoing public health crisis. Recent tragedies linked to diethylene glycol adulteration of cough syrups expose weaknesses in drug regulation, supply chain oversight, and market transparency, and need to be viewed through the lens of commercial determinants of health (CDoH)-the conditions, actions, and omissions by commercial actors that affect health. These incidents reflect intersections of high demand for cough syrups, irrational fixed-dose combinations, widespread over-the-counter sales, and limited public awareness on the one hand, and rising prices of pharmaceutical-grade glycerin and adulteration on the other hand. Addressing CDoH requires strict enforcement of regulatory system, alongside generating relevant evidence, advocacy and partnerships and dialogue with the commercial actors.
Indexed as
Identifiers
41499032What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.